Cargando…
Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis
Cutaneous melanoma (cM) is the deadliest of all primary skin cancers. Its prognosis is strongly influenced by the stage at diagnosis, with early stages having a good prognosis and being potentially treatable with surgery alone; advanced stages display a much worse prognosis, with a high rate of recu...
Autores principales: | Ricci, Costantino, Dika, Emi, Ambrosi, Francesca, Lambertini, Martina, Veronesi, Giulia, Barbara, Corti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180684/ https://www.ncbi.nlm.nih.gov/pubmed/35682589 http://dx.doi.org/10.3390/ijms23115911 |
Ejemplares similares
-
Cutaneous and Mucosal Melanomas of Uncommon Sites: Where Do We Stand Now?
por: Dika, Emi, et al.
Publicado: (2021) -
Cutaneous sarcoid‐like reaction in a patient treated with target therapy for metastatic melanoma: the hue is the clue
por: Baracca, Maria Francesca, et al.
Publicado: (2022) -
Basaloid follicular hamartomas in pediatric Basal Cell Nevus Syndrome: A diagnostic challenge
por: Besagni, Francesca, et al.
Publicado: (2021) -
The role of confocal microscopy in recurrent cutaneous angiosarcoma
por: Rossi, Alice Nadia, et al.
Publicado: (2023) -
BRAF V600K vs.
BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies
por: Zengarini, Corrado, et al.
Publicado: (2022)